Skip to content

Lyra G Series Surgical Laser System (SL Series Q-Switched Nd:YAG Configuration)

by Laserscope 2 variants

510(k) K010284

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

3 closed

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK010284 Date1 May 2001ClearedStatusActive

Recalls

3 recalls · FDA

    • Terminated Z-1229-2011 FDA Unclassified (pre-2012) initiated 8 Feb 2010

    A failure mode whereby the fiber attachment to the GreenLight PV laser system could inadvertently be broken. If fiber were to bend sharply at point of fiber connection, it may break and cause a burn.

    • Terminated Z-0131-2008 FDA Unclassified (pre-2012) initiated 18 Jun 2007

    Control knob break: The knob used to finely control the direction of the laser energy may break.

    • Terminated Z-0130-2008 FDA Unclassified (pre-2012) initiated 17 Apr 2007

    Component missing: Some products were issued without thermal protection switches.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
GEX
Device Class
Class II
Regulation
21 CFR Part 878.4810
Advisory Committee
General, Plastic Surgery
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Lyra G Series Surgical Laser System (SL Series Q-Switched Nd:YAG Configuration) is a Q-switched neodymium-doped yttrium aluminum garnet (Nd:YAG) laser designed for surgical applications. It delivers high-energy, short-duration laser pulses for precise tissue ablation, coagulation, and vascular lesion treatment, commonly used in dermatology and plastic surgery procedures.

This system is supplied as a reusable medical device intended for use in controlled clinical settings such as operating rooms or surgical suites. It is not sterile upon delivery and requires sterilization prior to use, adhering to standard surgical laser safety protocols. The device is regulated under FDA 510(k) clearance (K010284) and is classified under the General, Plastic Surgery advisory committee category. Compliance with manufacturer instructions for storage, maintenance, and operational safety is essential.

Other devices from Laserscope

See all devices from Laserscope →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What types of surgical procedures is the Lyra G Series Surgical Laser System primarily used for?

    The Lyra G Series Surgical Laser System (SL Series Q-Switched Nd:YAG) is designed for precise tissue ablation, coagulation, and treatment of vascular lesions, making it particularly useful in dermatology and plastic surgery. Its high-energy, short-duration pulses are ideal for procedures like tattoo removal, pigmented lesion treatment, and vascular lesion management, where controlled energy delivery is critical.

  • Is the Lyra G Series Surgical Laser System reusable, and if so, what sterilization process should be followed?

    Yes, the Lyra G Series Surgical Laser System is a reusable medical device. Since it is not sterile upon delivery, it must undergo sterilization prior to use following standard surgical laser safety protocols. The manufacturer’s instructions should be strictly adhered to for proper sterilization, storage, and maintenance to ensure safety and functionality in controlled clinical settings like operating rooms.

  • How is the Lyra G Series Surgical Laser System regulated, and what does its FDA clearance indicate?

    The Lyra G Series Surgical Laser System holds FDA 510(k) clearance under the classification of General, Plastic Surgery (reviewed by the Surgical Devices Subcommittee). The clearance indicates that the device is deemed substantially equivalent to a legally marketed predicate, meaning it meets regulatory standards for safety and effectiveness as determined by the FDA. This classification reflects its intended use in surgical applications, particularly in dermatology and plastic surgery.

  • What safety protocols should be followed when storing or maintaining this laser system?

    The Lyra G Series Surgical Laser System requires compliance with the manufacturer’s guidelines for storage, maintenance, and operational safety. Since it is reusable and not sterile upon delivery, proper sterilization procedures must be followed before use. Additionally, adherence to standard surgical laser safety protocols—such as proper handling, environmental controls, and regular equipment checks—is essential to prevent damage, ensure longevity, and maintain performance in clinical settings like operating rooms or surgical suites.